• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Epigenetics Drugs Diagnostic Technologies Companies

    ID: MRFR/HC/10457-CR
    128 Pages
    Rahul Gotadki
    July 2023

    Epigenetics is a field of study that investigates changes in gene expression without altering the underlying DNA sequence. Epigenetic drugs and diagnostic technologies companies focus on developing medications and diagnostic tools that target and analyze these epigenetic modifications. 

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Epigenetics Drugs and Diagnostic Technologies Market Research Report—Global Forecast till 2034 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Epigenetics Drugs Diagnostic Technologies Market

    Epigenetics Drugs Diagnostic Technologies Key Companies

     

    Latest Epigenetics Drugs Diagnostic Technologies Companies Update


    Illumina (US) Launched the CE IVD marked Next Generation Sequencing Instrument in March 2022, enabling both diagnostic testing and clinical research on a single platform.


    PacBio (US) Acquired Apton Biosystems (US) in August 2023 to accelerate the development of a high-throughput, short-read sequencer for epigenetic research.


    Epizyme (US) Received FDA Breakthrough Therapy Designation for EZH2 inhibitor tazemetostat in combination with chemotherapy for metastatic triple-negative breast cancer in December 2023.


    Celleon Therapeutics (US) Initiated Phase 1/2 clinical trial in October 2023 for TLX250, a first-in-class histone methyltransferase inhibitor for the treatment of advanced solid tumors.


    Twentyeight-seven Therapeutics (US) Announced positive interim data from Phase 1b/2 clinical trial for EPZ-6438, a DOT1L inhibitor for the treatment of acute myeloid leukemia (AML) in November 2023.


    List of Epigenetics Drugs Diagnostic Technologies Key Companies in the Market



    • Hologic, Inc. (US)

    • Gilead Sciences, Inc. (US)

    • Celleron Therapeutics (US)

    • Illumina, Inc. (US)

    • AstraZeneca PLC (UK)

    • LISEN lmprinting Diagnostics (US)

    • Salarius Pharmaceuticals, Inc. (US)

    • Jubilant Therapeutics (US)

    • Oryzon Genomics (Spain)

    • Epiaxis Therapeutics (Australia)